Tapentadol Hydrochloride Tablet, Film Coated
Product Images NDC 72205-369

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tapentadol Hydrochloride (NDC 72205-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tapentadol-tabs-100-mg-100s-cntr-lbl (Tapentadol Tabs 100 mg 100s Cntr Lbl)

Label for Tapentadol Tablets 100 mg film-coated oral tablets, containing tapentadol 100 mg per tablet. The label states Rx only, a package size of 100 tablets, manufacturer MSN Pharmaceuticals Inc., and distributor Novadoz Pharmaceuticals LLC. Storage instructions, caution against drug transfer, and medication guide dispensing instructions are included. The label features barcodes and the Novadoz logo.*

FDA Label Image

Tapentadol-tabs-50-mg-100s-cntr-lbl (Tapentadol Tabs 50 mg 100s Cntr Lbl)

Tapentadol Tablets 50 mg film-coated tablets packaging label showing the active ingredient strength and dosage form. The label states the quantity as 100 tablets and includes warnings about federal law and child safety. Distributed by Novadoz Pharmaceuticals LLC and manufactured by MSN Pharmaceuticals Inc., both located in Piscataway, NJ. Storage instructions and a link to print medication guides are also present.*

FDA Label Image

Tapentadol-tabs-75-mg-100s-cntr-lbl (Tapentadol Tabs 75 mg 100s Cntr Lbl)

Tapentadol Tablets 75 mg film-coated tablets label shows a 100-tablet bottle. The label includes storage instructions, manufacturer (MSN Pharmaceuticals Inc., Piscataway, NJ), and distributor (Novadoz Pharmaceuticals LLC) information with contact phone. The label features the Novadoz logo and the NDC number 72205-370-91, along with warnings about legal usage and medication guide dispensing.*

FDA Label Image

Tapentadol-tabs-figure-1 (Tapentadol Tabs Figure 1)

A line graph showing percent improvement in pain from baseline at hour 48 on the x-axis and percent of patients improved on the y-axis. It compares placebo and three strengths of Tapentadol (50 mg, 75 mg, and 100 mg) with distinct lines for each group, illustrating patient response rates across different improvement levels.*

FDA Label Image

Tapentadol-tabs-figure-2 (Tapentadol Tabs Figure 2)

A line graph comparing percent improvement in pain from baseline on Day 5 among patients treated with Tapentadol 50 mg, Tapentadol 75 mg, and placebo. The x-axis shows percent improvement in pain, and the y-axis shows the percent of patients improved. Tapentadol 50 mg and 75 mg show higher patient improvement percentages than placebo across various pain improvement levels.*

FDA Label Image

Tapentadol-tabs-structure (Tapentadol Tabs Structure)

Chemical structure diagram of Tapentadol Hydrochloride, showing the molecular arrangement of atoms including phenol group, alkyl chains, amine group, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.